Collagen in tumor matrix and damaged tissues is a common ligand for LAIR1 in broad spectrum, inhibiting immune cell functions after ligation, while LAIR2 was found to be a soluble protein with similar extracellular domain, which could block LAIR1 binding by competing ligands (55–58). This evidence concerns the gene LAIR2 and neoplasm.